Abstract
Wiskott-Aldrich Syndrome (WAS) is a severe X-linked disorder characterised by immune deficiency, thrombocytopenia and eczema, resulting from abnormalities in a range of haematopoietic cell types. The protein that is defective in WAS, named WASP, appears to be involved in regulating changes in the cytoskeletal organisation of haematopoietic cells in response to external stimuli. In support of this idea, WASP has been found to be physically associated in haematopoietic cells in vivo with a number of SH3 domain-containing proteins involved in signal transduction, including the cytoplasmic protein-tyrosine kinase Fyn. Here, we have used a baculovirus expression system to explore the biochemical consequences of the interaction between WASP and Fyn. We find that the kinase activity of Fyn is stimulated as a result of binding to WASP, and that a cellular protein, which may be WASP itself, becomes phosphorylated on tyrosine as a result of the binding of WASP to Fyn.
Similar content being viewed by others
References
Remold-O'Donnell E, Rosen FS & Kenney DM (1996) Blood 87: 2621–2631.
Brickell PM, Katz DR & Thrasher AJ (1998) Br. J. Haematol. 101: 603–608.
Gallego MD, Santamaria M, Pena J & Molina IJ (1997) Blood 90: 3089–3097.
Zicha D, Allen WE, Brickell PM, Kinnon C, Dunn GA, Jones GE & Thrasher AJ (1998) Br. J. Haematol. 101: 659–665.
Badolato R, Sozzani S, Malacarne F, Bresciani S, Fiorini M, Borsatti A, Albertini A, Mantovani A, Ugazio AG & Notarangelo LD (1998) J. Immunol. 161: 1026–1033.
Binks M, Jones GE, Brickell PM, Kinnon C, Katz DR & Thrasher AJ (1998) Eur. J. Immunol. 28: 3259–3267.
Semple JW, Siminovitch KA, Mody M, Milev Y, Lazarus AH, Wright JF, Freedman J (1997) Br. J. Haematol. 97: 747–754.
Derry JMJ, Ochs HJ & Francke U (1994) Cell 78: 635–644.
Symons M, Derry JMJ, Kariak B, Jiang S, Lemahieu V, McCormick F, Francke U & Abo A (1996) Cell 84: 723–734.
Aspenström P, Lindberg U & Hall A (1996) Curr. Biol. 6: 70–75.
Rivero-Lezcano OM, Marcilla A, Sameshima JH & Robbins KC (1995) Mol. Cell. Biol. 15: 5725–5731.
Miki H, Nonyama S, Zhu Q, Aruffo A, Ochs HD & Takenawa T (1997) Cell Growth Differ. 8: 195–202.
She HY, Rockow S, Tang J, Nishimura R, Skolnik EY, Chen M, Margolis B, Li W (1997) Mol. Biol. Cell 8: 1709–1721.
Wu Y, Dowbenko D, Lasky LA (1998) J. Biol. Chem. 273: 30487–30496.
Banin S, Truong O, Katz DR, Waterfield MD, Brickell PM & Gout I (1996) Curr. Biol. 6: 981–988.
Pleiman CM, D'Ambrosio D & Cambier JC (1994) Immunol. Today 15: 393–399.
Chan AC, Desai DM & Weiss A (1994) Ann. Rev. Immunol. 12: 555–592.
Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidle UH, Majdic O, Bartke I, Knapp W & Stockinger H (1995) J. Exp. Med. 181: 1381–1390.
Cory GOC, MacCarthy-Morrogh L, Banin S, Gout I, Brickell P, Levinsky RJ, Kinnon C & Lovering RC (1996) J. Immunol. 157: 3791–3795.
Finan PM, Soames CJ, Wilson L, Nelson DL, Stewart DM, Truong O, Hsuan JJ & Kellie S (1996) J. Biol. Chem. 271, 26291–26295.
Xu W, Harrison SC & Eck MJ (1997) Nature 385: 595–602.
Sicheri F, Moarefi I & Kuriyan J (1997) Nature 385: 602–609.
Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J & Miller WT (1997) Nature 385: 650–653.
Pawson T (1997) Nature 385: 582–583.
Gout I, Dhand R, Hiles ID, Fry MJ, Panayotou G, Das P, Truong O, Totty NF, Hsuan J, Booker GW, Campbell ID & Waterfield MD (1993) Cell 7: 25–36.
Koegl M, Kypta RM, Bergman M, Alitalo K & Courtneidge SA (1994) Biochem. J. 302: 737–744.
Guinamard R, Aspenström P, Fougereau M, Chavrier P, Guillemot JC (1998) FEBS Lett. 434: 431–436.
Oda A, Ochs HD, Druker BJ, Ozaki K, Watanabe C, Handa M, Miyakawa Y, Ikeda Y (1998) Blood 92: 1852–1858.
Schmitz R, Baumann G & Gram H (1996) J. Mol. Biol. 260: 664–677.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Banin, S., Gout, I. & Brickell, P. Interaction between Wiskott–Aldrich Syndrome Protein (WASP) and the Fyn protein-tyrosine kinase. Mol Biol Rep 26, 173–177 (1999). https://doi.org/10.1023/A:1006954206151
Issue Date:
DOI: https://doi.org/10.1023/A:1006954206151